Yiyang Tang

Mr. Yiyang Tang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2020 in Disease Markers
Verified
Journal Article
Open access
PDF file
YTYiyang Tang
Yiyang Tang
WLWenchao Lin
Wenchao Lin
LZLihuang Zha
Lihuang Zha
XZXiaofang Zeng
Xiaofang Zeng
XZXiaoman Zeng
Xiaoman Zeng
Zaixin YuZaixin Yu
Zaixin Yu
Background. Congestive heart failure (CHF) is a complex clinical syndrome, with high morbidity and mortality. Serum anion gap (SAG) is associated with the severity of various cardiovascular diseases. However, the role of SAG indicators in CHF is unclear. Methods and Results. A retrospective analysis of data from Multiparameter Intelligent Monitoring in Intensive Care III version 1.4 was conducted in critically ill patients with CHF. The clinical information of each patient, including demographic data, comorbidities, vital signs, scores, and laboratory indicators, were successfully obtained. Cox proportional hazards models were used to determine the relationship between SAG and mortality in patients with CHF, the consistency of which was further verified by subgroup analysis. Results. A total of 7426 subjects met the inclusion criteria. Multivariate analysis showed that after adjusting for age, gender, ethnicity, and other potential confounders, increased SAG was significantly related to an increase in 30- and 90-day all-cause mortalities of critically ill patients with CHF compared with decreased SAG (tertile 3 versus tertile 1: adjusted hazard ratio, 95% confidence interval: 1.74, 1.462.08; 1.53, 1.321.77). Subgroup analysis indicated that the association between SAG and all-cause mortality presented similarities in most strata. Conclusion. SAG at admission could be a promising predictor of all-cause mortality in critically ill patients with CHF.

13 May 2024 in Aging Cell
Verified
Journal Article
Open access
YTYiyang Tang
Yiyang Tang
ZLZhenghui Liu
Zhenghui Liu
QCQin Chen
Qin Chen
MJMukamengjiang Juaiti
Mukamengjiang Juaiti
ZYZaixin Yu
Zaixin Yu
LZlihuang zha
lihuang zha
The relationship between sarcopenia and the long‐term risk of atrial fibrillation (AF) remains unclear. This study recruited a large prospective Caucasian cohort from the UK Biobank. Participants were assessed at baseline with handgrip strength and muscle mass and were categorized into groups of non‐sarcopenia, probable sarcopenia, and confirmed sarcopenia. Kaplan–Meier method and Cox proportional hazards model were used to explore the association between sarcopenia and the incidence of AF. The genetic predisposition of AF was assessed by polygenic risk score. Sensitivity analyses were performed to validate the results. A total of 384,433 participants with a median age of 58 years and 54.3% women were enrolled in this study. There were 24,007 cases of new‐onset AF over a median follow‐up of 12.56 years. The groups of non‐sarcopenia, probable sarcopenia, and confirmed sarcopenia accounted for 22,290 (6.1%), 1665 (9.2%), and 52 (11.9%) cases, respectively. Compared with the non‐sarcopenia group, participants with probable sarcopenia or confirmed sarcopenia had an 8% (95% CI, 1.03–1.14) or 61% (95% CI, 1.23–2.12) higher risk of AF incidence. The findings remained robust in multiple sensitivity analyses, such as subgroup analysis and further adjustment of genetic predisposition. Notably, the association between sarcopenia and a high AF risk was more pronounced in younger participants, women, and those with valvular heart disease. In conclusion, sarcopenia was associated with a high long‐term risk of AF in Caucasians, supporting sarcopenia as a new independent risk factor of AF.

12 April 2024 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
BLBenhui Liang
Benhui Liang
LZLihuang Zha
Lihuang Zha
BPBaohua Peng
Baohua Peng
QCQin Chen
Qin Chen
MJMukamengjiang Juaiti
Mukamengjiang Juaiti
YTYiyang Tang
Yiyang Tang
Background The Life's Essential 8 (LE8) score, recently proposed by the American Heart Association, represents a new paradigm for evaluating cardiovascular health (CVH). We aimed to explore the association between CVH, estimated using LE8, and venous thromboembolism (VTE) incidence. Methods A total of 275,149 participants were recruited from the UK Biobank and divided into high (LE8 score ≥ 80), moderate (LE8 score < 80 but ≥ 50), and low (LE8 score < 50) CVH groups. Restricted cubic spline analysis, the Kaplan–Meier method, and the Cox proportional hazards model were used to explore the association between CVH and VTE. The genetic predisposition to VTE was assessed with a polygenic risk score. Sensitivity analyses were performed to validate the results. Results During a median follow-up of 12.56 years, VTE developed in 506 (4.09%), 6,069 (2.78%), and 720 (1.66%) participants with low, moderate, and high CVH levels, respectively. Compared with the low CVH group, participants in the moderate and high CVH groups had a 23% (hazard ratio [HR]: 0.77; 95% confidence interval [CI]: 0.71–0.85) and 41% (HR: 0.59; 95% CI: 0.52–0.66) lower risk of VTE, respectively, after adjusting for demographic characteristics, medical history, socioeconomic status, and genetic predisposition. This association remained robust in multiple sensitivity analyses. Higher CVH levels led to a more pronounced reduction in the risk of VTE in females and could appreciably offset the genetic risk of VTE. Conclusion Higher CVH levels were significantly associated with a lower incidence of VTE, encouraging efforts to increase LE8 scores in individuals. The data relevant to this study can be accessed from the UK Biobank Resource, available at www.ukbiobank.ac.uk. Please note that an application and subsequent official authorization are required to obtain the data. This study was conceived and designed by Y.T. B.L. and L.Z. were responsible for the extraction and analysis of the clinical data, as well as drafting the manuscript. B.P. and Q.C. assisted in the statistical analysis. M.J. and X.Z. contributed to implementing statistical methods and offered constructive suggestions. The manuscript was revised by Y.F. and Z.Y., who also participated in interpreting the results. All authors reviewed and approved the final manuscript. # These authors contributed equally. Received: 03 January 2024 Accepted: 11 April 2024 Accepted Manuscript online: 12 April 2024 Article published online: 07 May 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

1 August 2021 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
YTYiyang Tang
Yiyang Tang
QCQin Chen
Qin Chen
LZLihuang Zha
Lihuang Zha
YFYilu Feng
Yilu Feng
XZXiaofang Zeng
Xiaofang Zeng
Zaixin YuZaixin Yu
Zaixin Yu
Purpose: Acute myocardial infarction (AMI) is a common cardiovascular disease with a poor prognosis. The aim of this study was to construct a nomogram for predicting the long-term survival of critically ill patients with AMI. This nomogram will help in assessing disease severity, guiding treatment, and improving prognosis. Patients and Methods: The clinical data of patients with AMI were extracted from the MIMIC-III v1.4 database. Cox proportional hazards models were adopted to identify independent prognostic factors. A nomogram for predicting the long-term survival of these patients was developed on the basis of the results of multifactor analysis. The discriminative ability and accuracy of the multifactor analysis were evaluated according to concordance index (C-index) and calibration curves. Results: A total of 1202 patients were included in the analysis. The patients were randomly divided into a training set (n = 841) and a validation set (n = 361). Multivariate analysis revealed that age, blood urea nitrogen, respiratory rate, hemoglobin, pneumonia, cardiogenic shock, dialysis, and mechanical ventilation, all of which were incorporated into the nomogram, were independent predictive factors of AMI. Moreover, the nomogram exhibited favorable performance in predicting the 4-year survival of patients with AMI. The training set and the validation set had a C-index of 0.789 (95% confidence interval [CI]: 0.765– 0.813) and 0.762 (95% CI: 0.725– 0.799), respectively. Conclusion: The nomogram constructed herein can accurately predict the long-term survival of critically ill patients with AMI.

4 February 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
YFYilu Feng
Yilu Feng
Zaixin YuZaixin Yu
Zaixin Yu
MTMi Tang
Mi Tang
JLJiang Li
Jiang Li
BPBaohua Peng
Baohua Peng
JSJie Song
Jie Song
N6-methyladenosine (m6A) is a post-transcriptional epigenetic change with transcriptional stability and functionality regulated by specific m6A-modifying enzymes. However, the significance of genes modified by m6A and enzymes specific to m6A regulation in the context of pulmonary arterial hypertension (PAH) remains largely unexplored. MeRIP-seq and RNA-seq were applied to explore variances in m6A and RNA expression within the pulmonary artery tissues of control and monocrotaline-induced PAH rats. Functional enrichments were analyzed using the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes. To screen candidate m6A-related genes, the STRING and Metascape databases were used to construct a protein–protein interaction network followed by a real-time PCR validation of their expression. The expression level of an m6A regulator was further investigated using immunohistochemical staining, immunofluorescence, and Western blot techniques. Additionally, proliferation assays were conducted on primary rat pulmonary artery smooth muscle cells (PASMCs). We identified forty-two differentially expressed genes that exhibited either hypermethylated or hypomethylated m6A. These genes are predominantly related to the extracellular matrix structure, MAPK, and PI3K/AKT pathways. A candidate gene, centromere protein F (CENPF), was detected with increased expression in the PAH group. Additionally, we first identified an m6A reader, leucine rich pentatricopeptide repeat containing (LRPPRC), which was downregulated in the PAH rat model. The in vitro downregulation of Lrpprc mediated by siRNA resulted in the enhanced proliferation and elevated expression of Cenpf mRNA in primary rat PASMCs. Our study revealed a modified transcriptome-wide m6A landscape and associated regulatory mechanisms in the pulmonary arteries of PAH rats, potentially offering a novel target for therapeutic strategies in the future.

11 February 2020 in BMC Genomics
Verified
Journal Article
Open access
PDF file
Nan WangNan Wang
Nan Wang
JZJun Zhang
Jun Zhang
LXLi Xu
Li Xu
JQJing Qi
Jing Qi
BLBeibei Liu
Beibei Liu
SJShuilin Jin
Shuilin Jin
Background: With the rapid development of high-throughput sequencing technologies, many datasets on the same biological subject are generated. A meta-analysis is an approach that combines results from different studies on the same topic. The random-effects model in a meta-analysis enables the modeling of differences between studies by incorporating the between-study variance. Results: This paper proposes a moments estimator of the between-study variance that represents the across-study variation. A new random-effects method (DSLD2), which involves two-step estimation starting with the DSL estimate and the $D_{g}^{2}$Dg2 in the second step, is presented. The DSLD2 method is compared with 6 other meta-analysis methods based on effect sizes across 8 aspects under three hypothesis settings. The results show that DSLD2 is a suitable method for identifying differentially expressed genes under the first hypothesis. The DSLD2 method is also applied to Alzheimer’s microarray datasets. The differentially expressed genes detected by the DSLD2 method are significantly enriched in neurological diseases. Conclusions: The results from both simulationes and an application show that DSLD2 is a suitable method for detecting differentially expressed genes under the first hypothesis.